版本:
中国

Galapagos NV (GLPG.O)

GLPG.O ( 纳斯达克 )

119.21USD
22 May 2019
涨跌 (%)

$0.00 (+0.00%)
收盘
$119.21
开盘
$118.68
当日最高
$119.83
当日最低
$118.19
成交量
74,111
平均成交量
110,844
52 周最高
$125.48
52 周最低
$85.00

概况

无有关的概况信息

概况

无相关比率

财务指标

BRIEF-Galapagos, MorphoSys Announce Initiation Of Gecko Phase 2 Study

* GECKO IS A PHASE 2 STUDY TESTING A SUBCUTANEOUS FORMULATION OF MOR106 IN COMBINATION WITH TOPICAL CORTICOSTEROIDS IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS 全文
04/24 15:21

欧洲股市:收高,本季表现为四年最佳

路透3月29日 - 欧洲股市周五上涨,但收盘略低于盘中高点,此前英国议员第三次否决了英国首相特雷莎梅的退欧协议,增加了“无协议退欧”或延长英国退欧时间的可能性。 全文
03/30 02:08

UPDATE 2-European stocks rise, clocking best quarter in 4 years

* H&M among top gainers on STOXX after profits beat forecasts 全文
03/30 01:47

US STOCKS-Futures higher on trade optimism; inflation data awaited

March 29 U.S. stock index futures rose on Friday, the last trading day of the quarter, as the latest round of U.S.-China trade talks ended on a positive note and investors awaited inflation data. 全文
03/29 19:48

BRIEF-Galapagos Increases Share Capital Through Warrant Exercises

* ANNOUNCED ON WEDNESDAY SHARE CAPITAL INCREASE THROUGH WARRANT EXERCISES 全文
03/21 15:32

BRIEF-Galapagos FY Revenue Up At 317.8 Million Euros

* SAID ON THURSDAY FY REVENUE EUR 317.8 MLN VS EUR 155.9 MLN YR AGO 全文
02/22 15:10

BRIEF-Galapagos And Fibrocor Sign Partnership Focusing On Fibrosis

* SAID ON FRIDAY FIBROCOR THERAPEUTICS L.P. AND GALAPAGOS SIGN PARTNERSHIP FOCUSING ON FIBROSIS 全文
01/07 14:36

REFILE-Vertex posts positive data from cystic fibrosis triple combo trials

Nov 27 Vertex Pharmaceuticals Inc said on Tuesday that its triple combination therapy showed significant improvement in lung function in patients with cystic fibrosis (CF) in two late-stage clinical studies, sending its shares up 5 percent. 全文
11/28 02:10

BRIEF-Galapagos Increases Share Capital Through Warrant Exercises

* ANNOUNCED ON FRIDAY A SHARE CAPITAL INCREASE ARISING FROM WARRANT EXERCISES 全文
11/26 15:15

收益 vs. 预测